Cell fate depends on the interplay between chromatin regulators and transcription factors. Here we show that activity of the Mi-2b nucleosome-remodeling and histone-deacetylase (NuRD) complex was controlled by the Ikaros family of lymphoid lineagedetermining proteins. Ikaros, an integral component of the NuRD complex in lymphocytes, tethered this complex to active genes encoding molecules involved in lymphoid differentiation. Loss of Ikaros DNA-binding activity caused a local increase in chromatin remodeling and histone deacetylation and suppression of lymphoid cell-specific gene expression. Without Ikaros, the NuRD complex also redistributed to transcriptionally poised genes that were not targets of Ikaros (encoding molecules involved in proliferation and metabolism), which induced their reactivation. Thus, release of NuRD from Ikaros regulation blocks lymphocyte maturation and mediates progression to a leukemic state by engaging functionally opposing epigenetic and genetic networks.
A r t i c l e s
The fate of a cell is determined by the way that its genetic material and its protein scaffold, collectively called 'chromatin' , are modified. Chromatin influences the outcome of DNA-based processes such as transcription, replication, recombination and repair. The structure of chromatin is modulated in part by functionally diverse enzymes, which modify histones in the basic chromatin unit (the nucleosome), thereby providing direct or indirect modes of regulation of DNA accessibility. Histone acetylation can directly influence nucleosome configuration and is supportive of transcription initiation and elongation 1, 2 . Histone acetyltransferases and histone deacetylases (HDACs) have been shown to be concomitantly loaded on active genes, possibly in anticipation of transcriptional changes 3 . The Mi-2β nucleosomeremodeling and histone-deacetylase (NuRD) complex is one of several histone-deacetylase complexes present in mammalian cells but is unique in that it contains both chromatin-opening and chromatinclosing enzymatic activities 4, 5 . It has been hypothesized that the ATP-dependent nucleosome-remodeling activity of Mi-2β enables activity of the associated HDACs in the NuRD complex 4 . Chromatinmodifying and chromatin-remodeling enzymes are thought to be recruited to specific loci through association with sequence-specific DNA-binding factors, direct binding to preexisting histone modifications or other mechanisms 6 . In cells of the hematopoietic lineage, the NuRD complex stably associates with the Ikaros family of lymphoid lineage-determining DNA-binding factors 7, 8 . Thus, the association between the NuRD complex and Ikaros proteins provides a unique paradigm by which to delineate how chromatin regulation is harnessed for the benefit of key developmental transitions.
The Ikaros family comprises zinc-finger DNA-binding proteins that serve as key regulators of lymphocyte development, function and homeostasis 9 . Ikaros primes the lymphoid lineage potential of multipotent progenitors, and loss of Ikaros severs specification and commitment to the lymphoid lineage 10, 11 . After cells commit to the T cell lineage, more Ikaros activity is required for the homeostasis of differentiating precursors. Thymocytes past the double-negative (DN) stage of differentiation have high expression of members of both the Ikaros and Aiolos members of the Ikaros family 12 and are exquisitely sensitive to perturbations in the DNA-binding activity of Ikaros. A decrease in Ikaros that is not sufficient to interfere with early lymphoid-lineage 'decisions' nevertheless causes aberrant population expansion of CD4 + CD8 + (double-positive (DP)) thymocytes with intermediate expression of the T cell antigen receptor (TCR), which are reminiscent of cells undergoing TCR-mediated selection 13, 14 . Ikaros-deficient DP TCR + thymocytes, in response to a series of triggers, including activation of signaling via Notch oncogenic transcription factors, undergo further transition to a leukemic state 15, 16 .
Genetic studies of Ikaros and Mi-2β have independently established their participation in the same molecular processes but have also identified an unexpected functional antagonism 17, 18 . In multipotent hematopoietic progenitors, Ikaros promotes priming and commitment to the lymphoid lineage, whereas Mi-2β inhibits this process 11 (T.Y., data not shown). Loss of Ikaros results in illegitimate activation of Cd4 in DN thymocytes, whereas loss of Mi-2β results in illegitimate Cd4 silencing in DP thymocytes 18 . Similarly, loss of Ikaros causes aberrant T cell activation, whereas loss of Mi-2β interferes with T cell activation and proliferation 17, 19 . Ikaros-mutant mice develop T cell leukemia, whereas mice doubly deficient in both Ikaros and Mi-2β survive past 6 months and are disease free (data not shown). Despite its critical role in lymphocyte development and leukemogenesis, the molecular basis of the antagonism of Ikaros and Mi-2β remains elusive.
Through the use of that genetic system, we show here that in DP thymocytes, the NuRD complex contained both Ikaros and Aiolos and was targeted predominantly through common DNA-binding motifs to transcriptionally active genes encoding molecules involved in lymphoid differentiation. Loss of Ikaros correlated with a local gain in NuRD function, which was still recruited to those sites through Aiolos. We detected more nucleosome-remodeling and histonedeactylase activity that interfered with the recruitment of RNA polymerase II and lymphoid cell-specific gene expression. In addition, loss of Ikaros from the NuRD complex resulted in redistribution of NuRD to permissive chromatin of transcriptionally poised genes that were not targets of Ikaros (encoding molecules involved in cell growth and metabolism), which caused their reactivation. We thus propose that balanced targeting of the NuRD complex through lineage-specific DNA-binding factors and chromatin code is key to the timely induction of differentiation versus growth and proliferation genetic programs during development. Deregulation of this process causes differentiation arrest and leukemic transformation.
RESULTS

Composition of the NuRD complex in primary DP thymocytes
An association between the NuRD complex and Ikaros proteins has been reported in cycling T cells and erythroleukemia cells 7, 8 . We investigated whether this interaction also occurs in DP thymocytes, which constitute 85% of the primary thymocyte population. DP thymocytes are quiescent cells with abundant expression of Ikaros family proteins and that need to undergo TCR recombination and selection before differentiating into immunocompetent T cells 20 .
We purified two protein complexes from primary thymocytes through the use of epitope-tagged Mi-2β or Ikaros protein, from mice with transgenic expression of these ( Fig. 1a) . Mi-2β is an ATP-dependent nucleosome remodeler and an essential and nonredundant component of the NuRD complex that binds directly, and with high affinity, to Ikaros proteins 21 . We identified by protein microsequencing Ikaros, its family member Aiolos, and components of the NuRD complex, such as MTA1, MTA2, HDAC1, HDAC2, Rbp46 and Rbp48 ( Fig. 1 and Supplementary Table 1 ). Immunoblot analysis verified considerable enrichment of NuRD components in both complexes, relative to their abundance in unfractionated nuclear extracts ( Fig. 1b and Supplementary Table 1 ). That result was consistent with the purification of Ikaros-based complexes from actively cycling T cells 7 (Fig. 1a) . Thus, DNA-binding Ikaros proteins were stable components of the NuRD complex in quiescent DP thymocytes, as they were in cycling T cells.
Genome-wide targeting of the Ikaros-NuRD complex
The DNA-binding activity of Ikaros is required for lymphocyte development and homeostasis, and its ability to target chromatin remodeling in a sequence-specific manner has been proposed as its method of operation in the NuRD complex 9 . To test that hypothesis, we established the genome-wide distribution of Ikaros and Mi-2β in DP thymocytes by chromatin immunoprecipitation followed by DNA sequencing (ChIP-Seq). Ikaros bound to 7,120 sites, whereas Mi-2β bound to 4,158 sites (P < 10 −5 ); these were associated with 4,675 and 3,156 gene targets, respectively ( Fig. 2a and Table 1 ). Approximately 53% of the Mi-2β-binding sites and ~36% of the Ikaros-binding sites were associated with each other at the level of the gene, as identified by the closest transcription start site (TSS; P < 10 −320 ; Fig. 2a ). Ward hierarchical clustering centered on peaks of enrichment for either Ikaros or Mi-2β verified that proximity ( Fig. 2b and Supplementary  Fig. 1a,b ). Ikaros and Mi-2β were distributed similarly at six different genomic locations, with intergenic locations (40% versus 36%) and promoter-proximal locations (42% versus 47%) being the most prevalent ( Fig. 2c) . Together, the protein-complex purification and mapping studies confirmed that Ikaros works through the NuRD complex at distinct regulatory regions of the genome of DP cells.
The Ikaros-NuRD complex targets permissive chromatin We next examined the chromatin environment surrounding Ikaros and Mi-2β sites and the transcriptional state of their gene targets. Ward hierarchical clustering 22 centered on Ikaros sites at promoter-proximal locations (3 kilobases (kb) upstream or downstream of the TSS) showed extensive association with permissive modifications of histone H3 (tri-, di-or monomethylation of Lys4 (H3K4me3, H3K4me2 or H3K4me1, respectively) or acetylation of Lys9 (H3K9Ac)), as well as with RNA polymerase II ( Fig. 2b and Table 1 ). We observed a similar association at promoter-distal Ikaros sites (further than 3 kb from the TSS); depending on the distribution of H3K4me1, H3K4me2 and H3K4me3, we further classified these as strong or weak and/or poised enhancers 23 (Fig. 2b) . In contrast, there was little direct overlap between sites for Ikaros or Mi-2β and histone H3 trimethylated at Lys27 (H3K27me3), a mark of activity of the PRC2 polycomb complex Supplementary  Table 1 . Data are representative of more than two independent experiments.
A r t i c l e s and silent or bivalent chromatin 24, 25 . Nonetheless, the sites for Ikaros or Mi-2β and the H3K27me3 sites, although they did not overlap, were frequently (40%) associated at the level of the gene ( Table 1) .
RNA-expression analysis in DP thymocytes indicated that gene targets of Ikaros and Mi-2β were transcriptionally more active than genes not bound by these factors (Fig. 2d) . Approximately 70% of the gene targets of Ikaros and Mi-2β were enriched for the H3K36me3 transcription elongation mark ( Table 1) . As ~25% of the Ikaros and Mi-2β sites were in close proximity to promoters, we examined their distribution relative to the TSS (Fig. 2e) . The distribution of Ikaros was centered on the TSS, fitting in the groove generated by the nucleosomes marked by H3K4me3 and H3K9Ac-H3K14Ac that flank a transcriptionally active TSS. The distribution of RNA polymerase II overlapped that of Ikaros. Notably, Mi-2β showed a broader distribution over the TSS, covering the distribution of Ikaros, the two TSS-flanking nucleosomes and the distribution of RNA polymerase II. Thus, in DP thymocytes, Ikaros and Mi-2β associated mainly with transcriptionally active genes, frequently in the immediate vicinity of the RNA polymerase II complex, which indicates a direct role in the transcription cycle.
Loss and gain of Ikaros in NuRD chromatin enrichment
We evaluated the role of Ikaros in targeting the NuRD complex by comparing the distribution of Mi-2β in wild-type and Ikaros-null preleukemic thymocytes obtained from 3-to 5-week-old mice ( Fig. 3) . As noted for wild-type cells, a large proportion of Ikaros-null thymocytes were at the DP stage and had not activated Notch signaling, which is a late event in leukemic progression 16, 18 (and data not shown). We observed unexpected enrichment in the binding of Mi-2β to Ikarosnull chromatin (Fig. 3a,b) . This result was not due to greater abundance of Mi-2β mRNA or protein ( Fig. 3c and Supplementary Fig. 2 ). It was also not due to a global effect on chromatin accessibility, as binding of RNA polymerase II and other factors in the vicinity of Mi-2β sites was not greater (Fig. 3a,e ), which suggested a specific effect on Biological replicates for ChIP-Seq experiments with good overlap (>50%) were pooled and used for peak analysis and data presentation. Enrichment peaks for H3 modifications (H3K4me3, H3K4me2, H3K4me1, H3K9Ac, RNA polymerase II or H3K27me3) in wild-type chromatin were deduced from one ChIP-Seq experiment, as they showed expected correlation with each other and with regulatory domain distribution. Data are representative of two experiments (Ikaros, Mi-2β, H3K9Ac and RNA polymerase II in a-e) or one experiment (H3K4me3, H3K4me2, H3K4me1 and H3K27me3 in b,e). the access of Mi-2β to chromatin. Different methods of analysis with similar normalized reads from ChIP-Seq of Mi-2β in wild-type and Ikaros-null thymocytes consistently showed more enrichment for Mi-2β ( Fig. 3a and Supplementary Fig. 1c ). We found twofold more binding by Mi-2β at sites normally bound by Ikaros in wild-type cells ( Fig. 3a,b) , most of which were also occupied by Aiolos, the secondmost-prevalent member of the Ikaros family and component of the NuRD complex in thymocytes ( Figs. 1 and 3a) . However, we detected even more binding (>3.5-fold) at sites not bound by Ikaros and in genes that were not targets of Ikaros (Fig. 3a,b) .
Most of the new and pre-existing Mi-2β sites detected in Ikaros-null chromatin were in permissive chromatin, marked by H3K4me3, H3K9Ac and RNA polymerase II, with a small subset again associated with H3K27me3 ( Fig. 3a and Table 1) . Notably, the broad binding pattern of Mi-2β observed in wildtype cells became progressively narrower in Ikaros-null chromatin ( Fig. 3a,d ) in a manner that inversely correlated with the presence of Ikaros-type proteins in this complex. Thus, although more chromatin sites were occupied by Mi-2β in the absence of proteins of the Ikaros family, the binding pattern was more focused. Overall, the data suggested a gain in the accessibility of chromatin to the NuRD complex after loss of Ikaros.
Negative regulation of NuRD complex activity by Ikaros
We further evaluated the histone-modification status in proximity to Mi-2β sites in Ikaros-null and wild-type chromatin. Ward hierarchical clustering of Mi-2β sites in Ikaros-null chromatin showed much less histone acetylation in their immediate vicinity, detected with independent chromatin samples prepared from Ikaros-null preleukemic DP thymocytes ( Fig. 3a) . Cumulative distribution analysis centered on Mi-2β sites confirmed the much lower frequency of H3K9Ac-H3K14Ac. In fact, the majority of the genome-wide loss in H3K9Ac-H3K14Ac marks (67%) in Ikaros-null chromatin was directly associated with occupancy by Mi-2β (Supplementary Table 2 ). This analysis also showed more nucleosome remodeling in the vicinity of Mi-2β sites in Ikaros-null chromatin than in wild-type chromatin ( Fig. 3e) . Notably, we also detected ablation of H3K27me3 at the subset of Mi-2β sites marked by this modification in wild-type chromatin ( Fig. 3a,e ), which indicated potential antagonism between Mi-2β-NuRD and the PRC2 complex. In contrast to the much lower abundance of H3K9Ac, the overall changes in H3K4me3 and RNA polymerase II were relatively small ( Fig. 3a,e ). Nonetheless, most of the changes in RNA polymerase II were associated with higher occupancy by Mi-2β (Supplementary Table 2 ).
We further investigated the effect of the binding of Ikaros to DNA on the nucleosome-remodeling activity of Mi-2β in vitro ( Supplementary  Fig. 3 ). We generated mononucleosomes and nucleosomal arrays of twelve nuclesomes positioned by sea urchin 5S ribosomal gene DNA repeats. DNA templates contained Ikaros consensus sites, in addition to rotational phasing sequences. As a negative control, we used mutated DNA template with nonbinding Ikaros sites for mononucleosome assembly. The Ikaros-Mi-2β complex bound with specificity to both naked DNA and mononucleosomes containing Ikaros-binding sites but not to DNA or mononucleosomes without Ikaros sites ( Supplementary  Fig. 3a,b) . Notably, binding of the Ikaros-NuRD complex to mononucleosomes was stimulated by ATP. We confirmed Ikaros-specific binding to DNA by incubation with antibody to Ikaros; this resulted in less mobility of the Ikaros DNA-binding complex (Supplementary Fig. 3a ). DNA templates with and without Ikaros sites formed positioned mononucleosomes, as shown by the 10-base pair repeat generated by the limited cleavage by DNAse I at DNA sites facing away from the histone octamer ( Supplementary Fig. 3c ). At high concentrations of the Ikaros complex, Mi-2β (-Ik) WT ∆Ik
Distance to peak summit (kb) H3K27me3 (reads Supplementary Fig. 2) .
A r t i c l e s ATP-dependent disruption of the DNAse I cleavage pattern was demonstrated by characteristic enhancement and protection on both templates (mononucleosome remodeling). However, at lower concentrations of the Ikaros complex, remodeling occurred more often on nucleosomes without Ikaros sites. Similarly, competition with oligonucleotides containing Ikaros-binding sites provided more remodeling by the Ikaros complex and accessibility to restriction enzymes in 5S nucleosomal arrays (Supplementary Fig. 3d ). We observed no such effect with the hSWI-SNF nucleosome-remodeling complex (which does not contain Ikaros) purified from HeLa human cervical cancer cells.
Together, both the in vivo and in vitro studies provided evidence that binding of Ikaros to DNA had an inhibitory effect on the accessibility of chromatin to Mi-2β and nucleosome remodeling by Mi-2β. Sequencespecific binding of the Ikaros-NuRD complex on nucleosomes probably restricts access of Mi-2β to its nucleosomal substrate either through hindrance or by interference with the activity of the remodeler. Inhibition of the binding of Ikaros to sequence-specific DNA stimulates nucleosome remodeling by Mi-2β, which facilitates histone access and deacetylation. More nucleosome remodeling may also influence the access or activity of other chromatin modifiers, such as the PRC2 complex, when they are recruited in proximity to the NuRD complex.
Sequence-specific targeting of the Ikaros-NuRD complex
We investigated the DNA sequence specificity in the vicinity of binding sites for Ikaros and Mi-2β. We used the HOMER de novo motif-discovery algorithm to identify frequently occurring motifs in the vicinity of Ikaros sites at promoter-proximal and promoter-distal locations established in wild-type chromatin. Most of these sites were still occupied by Aiolos and Mi-2β in Ikaros-null chromatin, as determined by Ward's hierarchical clustering (Fig. 3a) .
Five Ikaros DNA-binding motifs established before in vitro 26, 27 showed considerable enrichment in the vicinity of Ikaros peaks in wild-type chromatin and of Aiolos peaks in Ikaros-null chromatin (Fig. 4a,b) , which indicated that both proteins targeted the NuRD complex to chromatin with similar sequence specificity. The most prevalent Ikaros motif detected at both promoter-proximal and distal locations (motif 1; 5′-ACAGGAAGT-3′) was similar to a variant of an Ets1 motif present in lymphoid cell-specific regulatory elements 28 . Some Ikaros motifs (such as motif 4) at promoters showed similarity to binding sites for STAT transcription factors, which suggested interaction between Ikaros and the Jak kinase-STAT pathway. HEB is a member of the E2A family of transcription factors that forms heterodimers with E2A and mediates common effects on gene expression and TCR selection required for T cell differentiation [29] [30] [31] . At promoter-distal Ikaros sites, we identified highly significant enrichment of E2A-HEB motifs (Fig. 4a,b) . We further investigated the association of Ikaros with E-box proteins by examining the genome-wide distribution of HEB in DP thymocytes. We detected a highly significant association between HEB and Ikaros at enhancer locations (Fig. 4c) .
E2A-binding sites have been shown to associate with Ikaros-like Ets1 motifs (Ikaros motif 1) and motifs for the transcription factor Runx1 at transcriptional enhancers active in B cell precursors 32 . We also observed a significant association between Ikaros sites and Runx motifs at enhancers in T cells (Fig. 4a,b) . Ikaros also acts through its cognate sites located at promoters and in proximity to basal transcription elements such as GC boxes and binding motifs for CREB and NRF1 (Fig. 4a,b) . Motifs for the transcription factor CTCF, which has insulator activity, were also associated with Ikaros at promoter and enhancer locations, albeit at lower frequency (Fig. 4a,b ). Together these studies showed conservation between T cell and B cell enhancers and a key role for the Ikaros-NuRD complex in regulating gene accessibility and expression, acting in concert with other key lymphoid lineage-specific transcription regulators.
Mode of NuRD targeting identifies distinct gene networks
Analysis of peaks of enrichment for Mi-2β in the vicinity of peaks of enrichment for Ikaros or Aiolos showed significant association with motifs for Ikaros and its lymphoid-factor associates (Fig. 5a) , which indicated direct recruitment through these DNA-binding factors. In contrast, peaks of enrichment for Mi-2β that were not in the vicinity of peaks of enrichment for Ikaros or Aiolos did not associate at any significant frequency with Ikaros or other lymphoid-factor motifs (Fig. 5a) . However, in both cases, Mi-2β sites were highly enriched for basal transcription elements such as GC boxes at promoters as well as with CTCF motifs at both promoter-proximal and distal regions (Fig. 5a) . Thus, in the presence of Ikaros, the NuRD complex is targeted mainly to lymphoid cell-specific regulatory regions highly enriched for Ikaros-, E2A-and Runx-binding sites, whereas in the absence of Ikaros, targeting occurs either via preexisting permissive chromatin codes such as H3K4me3 or through components of the basal transcription machinery.
Pathway analysis of genes targeted by the Ikaros-Mi-2β-NuRD complex or by the Mi-2β-NuRD complex alone has provided insight into the functional consequences of the differences in NuRD targeting in wild-type and Ikaros-null chromatin. Genes associated with Mi-2β-NuRD de novo sites in Ikaros-null chromatin that lacked A r t i c l e s DNA-binding motifs for Ikaros showed considerable and specific enrichment for pathways involved in cell growth such as mRNA, phospholipid metabolism and protein translation, as well as insulin, Wnt, Notch and mTOR signaling ( Fig. 5b and Supplementary Fig. 4) .
In contrast, lymphoid cell-specific genes encoding molecules and pathways involved in T cell activation, differentiation, migration and adhesion were specifically targeted by the Ikaros-NuRD complex ( Fig. 5b  and Supplementary Fig. 4 ). Both NuRD complexes associated with transcription, cell-cycle, DNA-damage, apoptosis and catabolic processes, albeit at different frequencies and with different gene targets ( Fig. 5b and Supplementary Fig. 4 ). Together these findings indicated that Mi-2β targets two classes of genetic networks that are functionally distinct: one is normally regulated by Ikaros and supports lymphocyte differentiation; the second is guided by permissive chromatin code or basal transcription mechanisms and supports cell growth and proliferation.
NuRD's opposing effects on differentiation and growth
We evaluated the transcriptional effects of Ikaros loss of function and Mi-2β-NuRD gain of function in DP thymocytes. We compared changes in the transcriptional elongation marker H3K36me3 in preleukemic Ikaros-null thymocytes with changes in RNA expression in DP thymocytes undergoing leukemic progression (preleukemic stages I and II) 16 . We defined a common signature of up-or downregulated genes (1,760 and 2,193 genes, respectively) by a change in both H3K36me3 and RNA expression ( Fig. 6a) .
Notably, this signature was progressively deregulated during leukemogenesis, with most genes directly associated with Mi-2β or the Ikaros family of proteins ( Fig. 6a and Supplementary Table 3 ). Downregulated genes had considerably fewer H3K9Ac-H3K14Ac modifications, as well as a less occupancy by RNA polymerase II (Fig. 6a,b ) that was more profound in the vicinity of Mi-2β or Ikaros-Aiolos sites (Supplementary Table 2) . Genes in the upregulated group were transcriptionally poised in wildtype chromatin, with H3K4me3 and H3K9Ac marks and with low frequency of occupancy by RNA polymerase II at the TSS and of the H3K36me3 elongation mark in the gene body (Fig. 6a) . We observed more occupancy by RNA polymerase II in the upregulated genes despite less H3K9Ac-H3K14Ac histone modification. Still, the abundance of H3K9Ac-H3K14Ac in the upregulated A r t i c l e s genes was greater than that in the downregulated genes ( Fig. 6a,  and Supplementary Fig. 5b ). In about one third of the upregulated genes, H3K27me3 was present in wild-type chromatin and absent from Ikaros-null chromatin ( Fig. 6a, Supplementary Figs. 5b and 6b and Supplementary Table 3 ). Notably, genes with the most significantly higher expression were frequently marked by H3K27me3 in wildtype chromatin (Fig. 6a) .
Analysis of gene ontology associated with the up-and downregulated gene subsets showed a 'division of labor' for the NuRD complex during T cell development (Supplementary Fig. 6 ). Pathways associated with T cell differentiation, activation, hematopoiesis, lymphoid and immune-system development and with substantial enrichment for the Ikaros-Mi-2β-NuRD complex were downregulated, whereas pathways supporting metabolism, and frequently with enrichment for the (Ikaros-free) Mi-2β-NuRD complex, were upregulated considerably (Supplementary Fig. 6) . We identified key genes encoding molecules involved in T cell differentiation, such as Cd4, Cd8, Rag1 and Rag2, Il4ra, Ifngr1, Ccnd3, Bcl2l1, Fas, Socs1,Tox, Pten and Ptprf, in the group downregulated by Ikaros-Mi-2β-NuRD. A substantial fraction of those genes were also directly associated with the E2A partner HEB ( Fig. 6c and Supplementary Fig. 7) . We identified genes encoding molecules that support basic cellular pathways in metabolism, cell growth, migration and proliferation, such as Nans, Nsun2, Rrn3, Alox5p, Adcy7, Insgfr1 and 2, Elovl6, Trib1, Ddr1, Vcl1, Dock1, Sdc1, Mmp14, Maged1, Ccnd1, Myc, Smo and Smad1, in the group upregulated by Mi-2β-NuRD (Supplementary Figs. 6 and 7) .
Together, the studies reported above indicated that during T cell differentiation, the NuRD complex regulated a range of genetic programs associated with differentiation, proliferation and growth by engaging functionally disparate mechanisms. However, the presence of Ikaros DNA-binding activity in the NuRD complex restricted its action to lymphoid-differentiation programs and the maintenance of gene expression. Loss of Ikaros unleashed NuRD activity to the full range of those genetic programs, thereby interfering with normal differentiation and causing aberrant growth and proliferation (Supplementary Fig. 8 ).
DISCUSSION
Our studies have provided insight into a mechanism that divides the labor of chromatin-remodeling complexes between differentiation-specific tasks and general cellular tasks, such as proliferation and growth. We have shown that targeting through lineage-specific DNA-binding factors positioned chromatin remodelers for the regulation of genetic programs that support differentiation while preventing their participation in programs that oppose differentiation. We have also shown that while they were tethered to lineage-specific genes, the activity of chromatinremodeling complexes was controlled by the DNA-binding activity of associated lineage-specific factors, which possibly served as a barrier to limit their access to chromatin. This potentially poised functional state provides an explanation for the steady-state association of restrictive chromatin modifiers with transcriptionally active genes 3 .
In the chromatin of both wild-type and Ikaros-null thymocytes, the NuRD complex was targeted to permissive chromatin, marked predominantly by H3K4me3, generated by the trithorax group of chromatin regulators 33 . The presence of Ikaros-type proteins in the NuRD complex further restricts this targeting to permissive chromatin that contains binding sites for Ikaros family proteins and the E-box and Runx family members, found frequently in lymphoid cell-specific regulatory elements. Here the chromatin-remodeling and histonedeacetylase activities of the NuRD complex were kept in check by Ikaros proteins, probably provided a physical barrier through DNA binding, that limited access to the nucleosome and its acetylated histone tails either by competition or by alteration of the conformation and enzymatic activity of Mi-2β. At active lymphocyte-specific genes, less binding of Ikaros to DNA resulted in more local access for Mi-2β, nucleosome remodeling and histone deacetylation and interfered with the transcription cycle and gene expression. In the absence of Ikaros, the related family member Aiolos, with similar DNA-binding specificity, still targeted the NuRD complex to those locations and limited local chromatin access, albeit not to the extent achieved by both factors acting together. Consistent with that model, more severely deleterious Ikaros-related phenotypes are observed in mice with combined null mutations in the genes encoding Ikaros and Aiolos or in mice and humans with dominant-negative mutations in the gene encoding Ikaros that interfere with the activity of both factors 9, 16, 34 .
Loss of binding of Ikaros to DNA allowed more access for Mi-2β not only at lymphoid cell-specific gene targets but also at transcriptionally poised genes encoding molecules involved in cell growth and metabolism. Gain of Mi-2β at these sites, normally present in permissive or bivalent chromatin, seemed to promote the transcription cycle and gene activation of RNA polymerase II. Notably, a fraction of those normally repressed genes were marked by occupancy with the PRC2 complex, and gain in occupancy by Mi-2β antagonized this chromatin modifier. Antagonistic interactions between PICKLE, the plant homolog of Mi-2β, and the polycomb protein CURLY LEAF have been shown to control expression of the genes encoding stem cell and meristem in Arabidopsis species 35 . Although those genes do not contain many Ikaros-binding motifs or other lymphoid cell-specific binding motifs, they contain basic transcriptional motifs, including binding sites for the CTCF insulator. Interaction between Mi-2β-NuRD and the cohesin complex that also interacts with CTCF has been reported 36, 37 , and we also detected this in our Mi-2β-NuRD complex purified from thymocytes. Functional interactions between the cohesin and basic transcriptionmediator complexes that enable communication between enhancer and core promoters in embryonic stem cells have been demonstrated 38 . A potential role for Mi-2β in regulating insulator function and possibly promoter-enhancer communication through interactions with the cohesin-CTCF and cohesin-mediator complexes indicates other mechanisms by which the NuRD complex participates in the induction of poised genes.
A change in the DNA-binding activity of proteins of the Ikaros family present in the NuRD complex may be the mechanism by which activity of this complex and expression of functionally opposing genetic programs is modulated from the most primitive lymphoid progenitor to the mature effector lymphocyte. Transcriptional and post-transcriptional events that target Ikaros expression and activity [39] [40] [41] [42] probably provide complexity in the regulation of the NuRD complex and may be key to successful transitions through the proliferative and quiescent stages of lymphocyte differentiation.
Association of the Ikaros-NuRD complex with both transcriptionally active and poised genes in thymocytes provides a 'snapshot' of their dual potential as activators and repressors of gene expression, which is probably dictated by the activity of neighboring factors. For example, Ikaros has been perceived as a repressor of Cd4 expression in DN thymocytes 18 , whereas our studies indicated that it also served to maintain Cd4 expression in DP thymocytes. The association of Ikaros with the inactive Cd4 locus at the DN stage may antagonize remodeling by Mi-2β, thus promoting the activity of negative regulators, such as the PRC2 complex. Less DNA-binding activity of Ikaros at the DN stage may result in more remodeling by Mi-2β that antagonizes local repressors and activates Cd4. Reinstating the DNA-binding activity of Ikaros and the Ikaros-NuRD complex at the transcriptionally active Cd4 locus in quiescent DP thymocytes bestows on Ikaros a previously unknown role as a guardian of Cd4 expression at this developmental stage. Less Ikaros activity at this DP stage or during subsequent transitions again results in more chromatin-remodeling activity by Mi-2β, which at this stage may antagonize the basal transcription machinery and thereby cause inactivation of Cd4.
Uncontrolled gain of function of the NuRD complex in DP thymocytes brought about disparate epigenetic effects that disrupted stagespecific activation and repression of genetic programs required for normal differentiation. Targeting of chromatin-modifying enzymes for therapeutic intervention, especially HDACs, is the focus of the treatment of T cell leukemias as well as debilitating immune disorders 43, 44 . Understanding the roles of HDAC complexes in the epigenetic regulation of differentiation versus cell growth and proliferation through their interactions with lineage-specific DNA-binding factors and other epigenetic regulators is important for the ability to manipulate cell-fate 'choices' and their aberrant manifestations in an intelligent way.
METHODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/natureimmunology/.
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